The manufacturer of a breast cancer drug which has been deemed "too expensive" to be offered by the NHS has hit back at the decision.
Dr Jayson Dallas, general manager of Roche Products Limited, declared it "an incredible injustice."
Despite Roche offering a significant discount, we are once again disappointed that Nice has not shown any flexibility on access to Kadcyla.
Refusing patients access to this drug is an incredible injustice and tantamount to turning the clock back in cancer research and development. We plan to appeal this decision.
More top news
Alex Salmond has not given up on his ambition for an independent Scotland and believes in future a 'yes' vote would win.
Dramatic video recorded during the return of NASA’s Orion through Earth’s atmosphere reveals intense conditions on the Orion spacecraft.
Rain will continue to fall in the north and west of England as the south remains largely dry for the start of the day.